Neurokinin 1 receptor signaling in endosomes mediates sustained nociception and is a viable therapeutic target for prolonged pain reliefDane D. Jensen, Nigel W. Bunnett, Νicholas Barlow et al.|Science Translational Medicine|2017Cited by 240
Critical Assessment of G Protein-Biased Agonism at the μ-Opioid ReceptorAlexander Gillis, Meritxell Canals, Andrea Kliewer et al.|Trends in Pharmacological Sciences|2020Cited by 157
Ubiquitination of CXCR7 Controls Receptor TraffickingMeritxell Canals, Rob Leurs|PLoS ONE|2012Cited by 108
Novel <scp>GPCR</scp> paradigms at the μ‐opioid receptorGary L. Thompson, Meritxell Canals, Eamonn Kelly et al.|British Journal of Pharmacology|2014Cited by 62
A tetrapeptide class of biased analgesics from an Australian fungus targets the µ-opioid receptorZoltan Dekan, MacDonald J. Christie, Setareh Sianati et al.|Proceedings of the National Academy of Sciences|2019Cited by 37